483 Woodfield Pharmaceutical Jul 2003

483 Woodfield Pharmaceutical Jul 2003

Kari Johansen FDA$595.00 - Available Now

FDA investigators audited the Woodfield Pharmaceutical - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 01 Jul 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Jul 2003
  • Location: Houston, United States
  • FEI: 1628196
Add To Cart